NATCO PHARMA Q2 FY25 Results
NATCO PHARMA has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 1,371.10 Cr
- Quarter-on-Quarter (QoQ) Change: 0.62% (Previous Quarter: Rs. 1,362.60 Cr )
- Year-on-Year (YoY) Change: 32.94% (Same Quarter Last Year: Rs. 1,031.40 Cr )
Profitability Metrics
- Net Profit: Rs. 676.50 Cr
- QoQ Profit Change: 1.20% (Previous Quarter: Rs. 668.50 Cr )
- YoY Profit Change: 83.33% (Same Quarter Last Year: Rs. 369.00 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 37.81
- QoQ EPS Change: 1.31% (Previous Quarter: Rs. 37.32)
- YoY EPS Change: 83.54% (Same Quarter Last Year: Rs. 20.60)
Performance Summary
Excellent
NATCO PHARMA did very well, with profits growing faster than sales. This means they're managing costs better.
This analysis provides a snapshot of NATCO PHARMA's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.